BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

Phase Scientific founder Ricky Chiu is drawing on his firm's pandemic experience to advance early detection methods through ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

“The collective world-wide evidence from 2020–2025 underscores a biologically plausible connection between COVID-19 vaccination and cancer.” Cancer remains a major global health concern, and ...

New research from the University of Minnesota Medical School is providing important insights into how COVID-19 persists in cancer patients even long after testing positive. The findings were recently ...

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...

The COVID-19 vaccine may give brain cancer patients a bonus shot at survival. Patients who received the vaccine within 100 days before biopsy or tumor surgery lived twice as long as those who didn’t ...

It’s ah-choo much for the body to handle. Viral infections like the flu and COVID-19 can “awaken” dormant breast cancer cells hiding in the lungs, paving the way for deadly metastatic disease, a new ...